BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33371144)

  • 1. A DNA methylation-associated nomogram predicts the overall survival of osteosarcoma.
    Shi J; Huang D; Zhang G; Zhao F; Yang L
    Medicine (Baltimore); 2020 Dec; 99(51):e23772. PubMed ID: 33371144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma.
    Wang H; Wei C; Pan P; Yuan F; Cheng J
    Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
    Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
    J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A methylomics-correlated nomogram predicts the recurrence free survival risk of kidney renal clear cell carcinoma.
    Zhu X; Ma X; Wu C
    Math Biosci Eng; 2021 Oct; 18(6):8559-8576. PubMed ID: 34814313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A methylomics-associated nomogram predicts the overall survival risk of stage III to IV ovarian cancer.
    Wei X; Hu W; Mao K
    Medicine (Baltimore); 2023 Feb; 102(5):e32766. PubMed ID: 36749233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 6 transcription factors-associated nomogram predicts the recurrence-free survival of thyroid papillary carcinoma.
    Wang T; Tian K; Ji X; Song F
    Medicine (Baltimore); 2021 Oct; 100(40):e27308. PubMed ID: 34622829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A methylomics-associated nomogram predicts recurrence-free survival of thyroid papillary carcinoma.
    Chen H; Ma X; Yang M; Wang M; Li L; Huang T
    Cancer Med; 2020 Oct; 9(19):7183-7193. PubMed ID: 32783399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying four DNA methylation gene sites signature for predicting prognosis of osteosarcoma.
    Zhang X; Zheng Y; Li G; Yu C; Ji T; Miao S
    Transl Cancer Res; 2020 Nov; 9(11):7299-7309. PubMed ID: 35117331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
    Wu G; Zhang M
    BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction.
    Xie L; Zeng J; He M
    BMC Cancer; 2023 Feb; 23(1):181. PubMed ID: 36814224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
    Li W; Liu J; Zhao H
    Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer.
    Wang Y; Zhang L; Wang B; Cheng Y
    Biomed Res Int; 2021; 2021():6699131. PubMed ID: 34337046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of an Autophagy-Related Clinical Prognosis Model for Predicting the Overall Survival of Osteosarcoma.
    Li J; Tang X; Du Y; Dong J; Zhao Z; Hu H; Song T; Guo J; Wang Y; Xu T; Shao C; Sheng Y; Xi Y
    Biomed Res Int; 2021; 2021():5428425. PubMed ID: 34604383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification system and web-based nomogram constructed for predicting the overall survival of primary osteosarcoma patients after surgical resection.
    Gao B; Wang MD; Li Y; Huang F
    Front Public Health; 2022; 10():949500. PubMed ID: 35991065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Validation of a Potent Multi-miRNA Signature for Prediction of Prognosis of Osteosarcoma Patients.
    Luo X; Tang J; Xuan H; Liu J; Li X
    Med Sci Monit; 2020 Feb; 26():e919272. PubMed ID: 32098942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation profiling to predict overall survival risk in gastric cancer: development and validation of a nomogram to optimize clinical management.
    Ma X; Chen H; Wang G; Li L; Tao K
    J Cancer; 2020; 11(15):4352-4365. PubMed ID: 32489454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Genomic-Clinicopathologic Nomogram Predicts Survival for Patients with Laryngeal Squamous Cell Carcinoma.
    Cui J; Wen Q; Tan X; Chen Z; Liu G
    Dis Markers; 2019; 2019():5980567. PubMed ID: 31827637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Prognosis Signature Based on Ferroptosis-Related Gene DNA Methylation Data for Lung Squamous Cell Carcinoma.
    Wang X; Meng Y; Liu C; Yang H; Zhou S
    J Oncol; 2022; 2022():9103259. PubMed ID: 36131791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes.
    Bai Y; Wei C; Zhong Y; Zhang Y; Long J; Huang S; Xie F; Tian Y; Wang X; Zhao H
    Int J Biol Sci; 2020; 16(7):1153-1165. PubMed ID: 32174791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.